Jordan C Knight1, Stephen Lehnert2, Anthony L Shanks3, Lamia Atasi3, Lisa R Delaney2, Megan B Marine2, Sherrine A Ibrahim3, Brandon P Brown2. 1. Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Indiana University School of Medicine, 550 N. University Blvd., UH 2440, Indianapolis, IN, 46202, USA. jodeknight@yahoo.com. 2. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA. 3. Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Indiana University School of Medicine, 550 N. University Blvd., UH 2440, Indianapolis, IN, 46202, USA.
Abstract
BACKGROUND: Ultrasound (US) is the first-line imaging modality to assess the morbidly adherent placenta, but sensitivity and specificity are lacking. OBJECTIVE: This investigation aims to improve diagnostic accuracy with a comprehensive score using clinical history, US, and magnetic resonance imaging (MRI). MATERIALS AND METHODS: We conducted a retrospective cohort study of pregnant women who received both transvaginal US and MRI with suspicion for morbidly adherent placenta between 2009 and 2016. US was scored with the following metrics: (i) previa, (ii) hypervascularity, (iii) loss of retroplacental clear space and (iv) lacunae. MRI was evaluated for (i) intraparenchymal vessels, (ii) abnormally dilated vessels, (iii) fibrin deposition, (iv) placental bulge and (v) bladder dome irregularity. Bayesian analysis was used to estimate the probability of morbidly adherent placenta for a given score. Diagnostic testing parameters were calculated. RESULTS: Among the 41 women with concerning imaging, histologically identified disease was confirmed in 16. The probability of morbidly adherent placenta increased with the score. At the highest US score, the probability of disease was 63.7%. With the highest MRI score, the probability of adherent placentation was 90.5%. Combining the US and MRI findings had a sensitivity of 56% and a specificity of 92%. CONCLUSION: A combined scoring system using MRI and US may accurately identify patients at risk for morbidity associated with morbidly adherent placenta.
BACKGROUND: Ultrasound (US) is the first-line imaging modality to assess the morbidly adherent placenta, but sensitivity and specificity are lacking. OBJECTIVE: This investigation aims to improve diagnostic accuracy with a comprehensive score using clinical history, US, and magnetic resonance imaging (MRI). MATERIALS AND METHODS: We conducted a retrospective cohort study of pregnant women who received both transvaginal US and MRI with suspicion for morbidly adherent placenta between 2009 and 2016. US was scored with the following metrics: (i) previa, (ii) hypervascularity, (iii) loss of retroplacental clear space and (iv) lacunae. MRI was evaluated for (i) intraparenchymal vessels, (ii) abnormally dilated vessels, (iii) fibrin deposition, (iv) placental bulge and (v) bladder dome irregularity. Bayesian analysis was used to estimate the probability of morbidly adherent placenta for a given score. Diagnostic testing parameters were calculated. RESULTS: Among the 41 women with concerning imaging, histologically identified disease was confirmed in 16. The probability of morbidly adherent placenta increased with the score. At the highest US score, the probability of disease was 63.7%. With the highest MRI score, the probability of adherent placentation was 90.5%. Combining the US and MRI findings had a sensitivity of 56% and a specificity of 92%. CONCLUSION: A combined scoring system using MRI and US may accurately identify patients at risk for morbidity associated with morbidly adherent placenta.
Authors: Carri R Warshak; Ramez Eskander; Andrew D Hull; Angela L Scioscia; Robert F Mattrey; Kurt Benirschke; Robert Resnik Journal: Obstet Gynecol Date: 2006-09 Impact factor: 7.661
Authors: Martha W F Rac; Jodi S Dashe; C Edward Wells; Elysia Moschos; Donald D McIntire; Diane M Twickler Journal: Am J Obstet Gynecol Date: 2014-10-18 Impact factor: 8.661
Authors: S L Collins; A Ashcroft; T Braun; P Calda; J Langhoff-Roos; O Morel; V Stefanovic; B Tutschek; F Chantraine Journal: Ultrasound Obstet Gynecol Date: 2016-03 Impact factor: 7.299
Authors: F D'Antonio; C Iacovella; J Palacios-Jaraquemada; C H Bruno; L Manzoli; A Bhide Journal: Ultrasound Obstet Gynecol Date: 2014-06-02 Impact factor: 7.299
Authors: Alexandra G Eller; Michele A Bennett; Margarita Sharshiner; Carol Masheter; Andrew P Soisson; Mark Dodson; Robert M Silver Journal: Obstet Gynecol Date: 2011-02 Impact factor: 7.661
Authors: Valeria Romeo; Francesco Verde; Laura Sarno; Sonia Migliorini; Mario Petretta; Pier Paolo Mainenti; Maria D'Armiento; Maurizio Guida; Arturo Brunetti; Simone Maurea Journal: Radiol Med Date: 2021-06-22 Impact factor: 3.469